Visium Asset Management’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Visium Asset Management’s Portfolio TCON Stock Details TCON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-462	Closed	-$405K	–	205
2016 Q2	$405K	Sell	462 -1,538	-77%	-$2.04M	0.03%	281
2016 Q1	$2.8M	Sell	2,000 -182	-8%	-$259K	0.05%	349
2015 Q4	$4.03M	Hold	2,182	–	–	0.06%	310
2015 Q3	$4.26M	Hold	2,182	–	–	0.06%	324
2015 Q2	$4.94M	Sell	2,182 -125	-5%	-$293K	0.07%	283
2015 Q1	$6.48M	Buy	+2,307	New	+$6.06M	0.1%	209

Other funds holding TCON

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

WSA

Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

CAM

ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

SII Investments Appleton, Wisconsin $965M AUM 15.44% 1-Year Est. Return

Visium Asset Management's TCON Position: Q3 2016 in Review

Visium Asset Management sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q3 2016, closing a stake of 462 shares — an estimated $405K sold.

Visium Asset Management first reported a position in TCON in Q1 2015 and held it in 6 quarters. The position peaked at $6.48M in Q1 2015. 25 funds tracked by Wall St. Rank hold TCON as of Q3 2016.

Visium Asset Management reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
Visium Asset Management sold 462 TRACON Pharmaceuticals, Inc. Common Stock shares in Q3 2016, an estimated $405K.
Visium Asset Management first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q1 2015 and held it in 6 quarters.
Visium Asset Management's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $6.48M in Q1 2015.
25 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q3 2016.

Based on Visium Asset Management's 13F filing for Q3 2016.